Your browser doesn't support javascript.
loading
Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease.
Nissen, Steven E; Wolski, Kathy; Cho, Leslie; Nicholls, Stephen J; Kastelein, John; Leitersdorf, Eran; Landmesser, Ulf; Blaha, Michael; Lincoff, A Michael; Morishita, Ryuichi; Tsimikas, Sotirios; Liu, Junhao; Manning, Brian; Kozlovski, Plamen; Lesogor, Anastasia; Thuren, Tom; Shibasaki, Taro; Matei, Florin; Silveira, Fábio Serra; Meunch, Andreas; Bada, Aysha; Vijan, Vinod; Bruun, Niels Eske; Nordestgaard, Borge G.
Affiliation
  • Nissen SE; Cleveland Clinic Cardiovascular Coordinating Center, Cleveland, Ohio, USA nissens@ccf.org.
  • Wolski K; Cleveland Clinic Cardiovascular Coordinating Center, Cleveland, Ohio, USA.
  • Cho L; Cleveland Clinic Cardiovascular Coordinating Center, Cleveland, Ohio, USA.
  • Nicholls SJ; Victorian Heart Institute, Monash University, Clayton, Victoria, Australia.
  • Kastelein J; Academic Medical Center, Amsterdam, The Netherlands.
  • Leitersdorf E; Department of Medicine, Hadassah Medical Center, Jerusalem, Israel.
  • Landmesser U; Israel and Faculty of Medicine, the Hebrew University, Jerusalem, Israel.
  • Blaha M; Department of Cardiology, Charité University Medicine Berlin, German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin Institute of Health, Berlin, Germany.
  • Lincoff AM; Johns Hopkins, Ciccarone Center for the Prevention of Cardiovascular Disease, Baltimore, Maryland, USA.
  • Morishita R; Cleveland Clinic Cardiovascular Coordinating Center, Cleveland, Ohio, USA.
  • Tsimikas S; Center of Medical Innovation and Translational Research School of Medicine, Osaka University, Suita, Osaka, Japan.
  • Liu J; Division of Cardiovascular Medicine, University of California San Diego, La Jolla, California, USA.
  • Manning B; Novartis Pharmaceuticals, East Hanover, New Jersey, USA.
  • Kozlovski P; Novartis Pharmaceuticals, East Hanover, New Jersey, USA.
  • Lesogor A; Novartis Pharma AG, Basel, Switzerland.
  • Thuren T; Novartis Pharma AG, Basel, Switzerland.
  • Shibasaki T; Novartis Pharmaceuticals, East Hanover, New Jersey, USA.
  • Matei F; Saitama Sekishinkai Hospital, Sayama-city, Saitama, Japan.
  • Silveira FS; Clinica Matcord, Buzau, Romania.
  • Meunch A; Research Center Clínica do Coração, Aracaju-SE, Brazil.
  • Bada A; SEC Clinical Research, Andalusia, Alabama, USA.
  • Vijan V; Chris Hani Baragwanath Hospital, Soweto, South Africa.
  • Bruun NE; Vijan Cardiac & Critical Care Centre, Maharashtra, India.
  • Nordestgaard BG; Zealand University Hospital, Roskilde, Denmark.
Open Heart ; 9(2)2022 10.
Article in En | MEDLINE | ID: mdl-36252994
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Brain Ischemia / Stroke / Atherosclerosis Type of study: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Open Heart Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Brain Ischemia / Stroke / Atherosclerosis Type of study: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Open Heart Year: 2022 Document type: Article Affiliation country: